These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 22512837)

  • 21. ALS issues in clinical trials. Missing data.
    Thompson JL; Levy G
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():48-51. PubMed ID: 15512872
    [No Abstract]   [Full Text] [Related]  

  • 22. The quality of reports of randomized trials in multiple sclerosis: a review.
    Signori A; Baccino A; Sormani MP
    Mult Scler; 2012 Jun; 18(6):776-81. PubMed ID: 22495947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The clinician as investigator: participating in clinical trials in the practice setting: Appendix 2: statistical concepts in study design and analysis.
    Lader EW; Cannon CP; Ohman EM; Newby LK; Sulmasy DP; Barst RJ; Fair JM; Flather M; Freedman JE; Frye RL; Hand MM; Jesse RL; Van de Werf F; Costa F;
    Circulation; 2004 Jun; 109(21):e305-7. PubMed ID: 15173053
    [No Abstract]   [Full Text] [Related]  

  • 24. Review of randomized controlled trials: issues to consider when designing a trial.
    Pandis N
    Am J Orthod Dentofacial Orthop; 2013 Jun; 143(6):905-7. PubMed ID: 23726342
    [No Abstract]   [Full Text] [Related]  

  • 25. A statistic to avoid being misled by the "winners curse".
    Tugwell P; Knottnerus JA
    J Clin Epidemiol; 2018 Nov; 103():vi-viii. PubMed ID: 30293635
    [No Abstract]   [Full Text] [Related]  

  • 26. Statistical principles: myths or facts?
    Sylvester R
    Onkologie; 2003 Dec; 26(6):520-1. PubMed ID: 14709923
    [No Abstract]   [Full Text] [Related]  

  • 27. Statistical trial designs and clinical practice: are they compatible?
    Punt CJ
    Onkologie; 2003 Dec; 26(6):518-9. PubMed ID: 14709922
    [No Abstract]   [Full Text] [Related]  

  • 28. Subgroup analyses.
    Oxman AD
    BMJ; 2012 Mar; 344():e2022. PubMed ID: 22422834
    [No Abstract]   [Full Text] [Related]  

  • 29. Designing randomised trials: both large and small trials are needed.
    Stenning SP; Parmar MK
    Ann Oncol; 2002; 13 Suppl 4():131-8. PubMed ID: 12401679
    [No Abstract]   [Full Text] [Related]  

  • 30. Re: The design versus the analysis of observational studies for causal effects: parallels with the design of randomized trials.
    Shrier I
    Stat Med; 2008 Jun; 27(14):2740-1; author reply 2741-2. PubMed ID: 18069729
    [No Abstract]   [Full Text] [Related]  

  • 31. Adverse events in randomized trials: neglected, restricted, distorted, and silenced.
    Ioannidis JP
    Arch Intern Med; 2009 Oct; 169(19):1737-9. PubMed ID: 19858427
    [No Abstract]   [Full Text] [Related]  

  • 32. Cost data for individual patients included in clinical studies: no amount of statistical analysis can compensate for inadequate costing methods.
    Graves N; Walker D; Raine R; Hutchings A; Roberts JA
    Health Econ; 2002 Dec; 11(8):735-9. PubMed ID: 12457373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reporting of sample-size calculations for randomized trials in dermatology: comparison of publications with registries.
    Weinberg T; Wang G; Lam K; Kitchen J; Chan AW
    Br J Dermatol; 2019 Apr; 180(4):929-930. PubMed ID: 30339744
    [No Abstract]   [Full Text] [Related]  

  • 34. Is Propensity Score Analysis a Valid Surrogate of Randomization for the Avoidance of Allocation Bias?
    Torres F; Ríos J; Saez-Peñataro J; Pontes C
    Semin Liver Dis; 2017 Aug; 37(3):275-286. PubMed ID: 28847037
    [No Abstract]   [Full Text] [Related]  

  • 35. Reported methodological quality of split-mouth studies.
    Lesaffre E; Garcia Zattera MJ; Redmond C; Huber H; Needleman I;
    J Clin Periodontol; 2007 Sep; 34(9):756-61. PubMed ID: 17716311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sympathetic bias.
    Levy DM; Peart SJ
    Stat Methods Med Res; 2008 Jun; 17(3):265-77. PubMed ID: 17925315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sample size calculations for randomized controlled trials.
    Wittes J
    Epidemiol Rev; 2002; 24(1):39-53. PubMed ID: 12119854
    [No Abstract]   [Full Text] [Related]  

  • 38. Randomized clinical trials and observational studies: guidelines for assessing respective strengths and limitations.
    Hannan EL
    JACC Cardiovasc Interv; 2008 Jun; 1(3):211-7. PubMed ID: 19463302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alternatives to Randomised Controlled Trials for the Poor, the Impatient, and When Evaluating Emerging Technologies.
    Mani K; Björck M
    Eur J Vasc Endovasc Surg; 2019 Apr; 57(4):598-599. PubMed ID: 30509892
    [No Abstract]   [Full Text] [Related]  

  • 40. Randomized controlled trials.
    Jainer AK; Chawla M
    Am J Psychiatry; 2003 Jun; 160(6):1189-90; author reply 1190. PubMed ID: 12777289
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.